Study to Assess VB-201 in Patients With Psoriasis
Public ClinicalTrials.gov record NCT01001468. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, 12-Week, Dose-Ranging Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral VB-201 in Patients With Moderate to Severe Plaque Psoriasis
Study identification
- NCT ID
- NCT01001468
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Vascular Biogenics Ltd. operating as VBL Therapeutics
- Industry
- Enrollment
- 185 participants
Conditions and interventions
Conditions
Interventions
- VB-201 Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2009
- Primary completion
- Jun 30, 2011
- Completion
- Jun 30, 2011
- Last update posted
- Nov 15, 2011
2009 – 2011
United States locations
- U.S. sites
- 10
- U.S. states
- 4
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alexa Kimball, MD, Massachusetts General and Brigham and Women's Hospital | Boston | Massachusetts | 02114 | — |
| Mark Amster, MD, Boston Clinical Trials | Boston | Massachusetts | 02135 | — |
| David Greenstein, MD, ActivMed Practices and Research | Haverhill (Boston) | Massachusetts | 01830 | — |
| Craig Leonardi, MD, Central Dermatology | St Louis | Missouri | 63117 | — |
| Bruce Strober, MD, New York University Medical Center, Dermatologic Associates | New York | New York | 10016 | — |
| Gary Goldenberg, MD, Mount Sinai School of Medicine | New York | New York | 10029 | — |
| Julian MacKay Wiggan, MD, Columbia University Medical Center | New York | New York | 10032 | — |
| Steven Cohen, MD, Montefiore Medical Center, Dermatology | New York | New York | 10467 | — |
| Joseph D. Sutton, MD, PC | Suffern | New York | 10901 | — |
| Kristina Callis-Duffin, MD, University of Utah | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01001468, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 15, 2011 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01001468 live on ClinicalTrials.gov.